‘The Front Line COVID-19 Critical Care Alliance (FLCCC) has issued a public statement in response to a press release recently issued by Merck.
‘The FLCCC Alliance reports that the Merck release of February 4, 2021— which concluded that there was no meaningful evidence for the clinical efficacy of ivermectin in patients with COVID-19 disease — did not provide any scientific data or analyses by Merck to support their conclusion.
‘Dr. Pierre Kory, President and Chief Medical Officer of the FLCCC said that, "The company's disregard for the most current medical evidence is an evidentiary indictment of their uncorroborated position. Merck's press release will cause governments, health authorities, medical providers, business leaders, and citizens to retreat from pursuing a medical agent that, according to our recent peer-reviewed and accepted publication to the highly regarded Frontiers in Pharmacology, has been proven to be an effective and globally available agent to prevent and treat every phase of COVID-19 disease."
Read here (PRWeb, Feb 16, 2021)
